Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Mechanisms Driving the Resolution of Inflammation




for Members

Mechanisms Driving the Resolution of Inflammation

Wednesday, January 29, 2020, 11:30 AM - 12:45 PM EST

The New York Academy of Sciences
115 Broadway, 8th Floor
New York, NY 10006, New York City, 10006 USA

Presented By

The New York Academy of Sciences


Inflammation is a common feature of many widely occurring human diseases. This 75 minute webinar will explore recent research on the molecular mechanisms driving resolution of inflammation and approaches to therapeutically target these pathways in chronic inflammatory and autoimmune diseases.

Access the eBriefing from this webinar here. This eBriefing will remain open access for 60 days, after which it will be open to Members only. Join today.

In This Webinar, You’ll Learn

  • The key steps required for the successful resolution of inflammation.
  • How pro-resolving mediators, including lipoxins, resolvins, maresins, and protectins are biosynthesized and how they regulate resolution.
  • How defects in resolution pathways contribute to chronic autoimmune and inflammatory conditions, including diabetes.
  • Emerging strategies to therapeutically target the resolution of inflammation.
Charles Serhan

Charles Serhan, PhD, DSc
Harvard Medical School

Charles N. Serhan is a leading authority in inflammatory resolution and was first to identify the role of pro-resolving cellular mediators such as resolvins and lipoxins. He is the Simon Gelman Professor of Anesthesia at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine. He directs the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. Charles received his BS from Stony Brook University and his doctorate from NYU School of Medicine. He was a post-doctoral fellow at the Karolinska Institutet, Stockholm and joined the faculty at Harvard Medical School in 1987.

Catherine Godson

Catherine Godson, PhD
University College Dublin

Catherine Godson studies the innate immune system and chronic complications of diabetes. Her research on inflammatory processes underlying diabetic complications has led to the identification of several novel therapeutic targets, susceptibility genes and potential modulators of disease. She is Professor of Molecular Medicine at University College Dublin (UCD) and Director of the UCD Diabetes Complications Research Centre. She was elected a member of the Royal Irish Academy in 2011 and will receive the Women in Science Award of The International Congress of Inflammation in 2019.

Access to Webinar Materials

A link to the eBriefing (video recording) of this Webinar will be available to all registrants within 30 days of the event date.  The eBriefing will be available to all registrants for 60 days following publication, after which it will revert to Member-only access. Not a Member? Join today.